Official Clinical Care Algorithms for Managing Bilateral Polyposis

Bilateral nasal polyposis—when polyps form on both sides of the nasal passages—is a common feature of chronic rhinosinusitis with nasal polyps (CRSwNP). Multiple international and national bodies (including EPOS, the European Position Paper on Rhinosinusitis and Nasal Polyps, and the American Academy of Otolaryngology–Head and Neck Surgery) have published evidence-based clinical algorithms. Below is a clear, step-by-step overview of what doctors follow in everyday practice.

---

1. Initial Assessment and Diagnosis

1. History & Symptom Evaluation

   • Nasal obstruction or congestion
   • Anosmia (loss of smell) or hyposmia (reduced smell)
   • Rhinorrhea (anterior/posterior drip)
   • Facial pain or pressure
   • Duration ≥ 12 weeks

2. Physical Examination

   • Nasal endoscopy (office-based)
     • Visible pale, edematous polyps on both sides
   • Anterior rhinoscopy (if endoscopy unavailable)

3. Imaging

   • CT scan of the sinuses (coronal cuts preferred)
     • Assess extent (Lund–Mackay score)
     • Rule out complications (orbital, intracranial)

4. Laboratory & Comorbidity Workup

   • Allergy testing (skin prick or specific IgE)
   • Blood eosinophil count
   • Aspirin (NSAID)-exacerbated respiratory disease (AERD) evaluation
   • Asthma assessment (spirometry, FeNO if available)

5. Severity Stratification

   • Polyp Grade (0–4 per side)
   • Symptom Score (e.g., SNOT-22)
   • CT Score (0–24)
   • Comorbidities present (asthma, allergy, AERD)

---

2. First-Line Medical Management

Goal: Reduce polyp size, improve symptoms, prevent progression.

• Intranasal Corticosteroids (INCS)
– Mometasone, fluticasone, budesonide sprays
– Daily use, proper head position to maximize sinus delivery

• Nasal Saline Irrigation
– Isotonic or hypertonic saline, 100–200 mL per nostril daily
– Enhances mucociliary clearance, reduces crusting

• Short-Course Oral Corticosteroids
– Prednisone 25–50 mg daily for 5–7 days
– Reserved for moderate-to-severe polyps or severe symptoms

• Antibiotics (if infection suspected)
– Doxycycline, macrolides (anti-inflammatory effect)
– Course 3–4 weeks in selected patients

• Allergy Control
– Intranasal antihistamines
– Immunotherapy if indicated

Re-evaluate after 4–6 weeks of therapy:

• Assess polyp size (endoscopy)
• Symptom improvement (patient-reported outcome)

---

3. Step-Up Care for Refractory Disease

If initial medical therapy fails (persistent grade ≥ 2 polyps, poor quality of life), follow a step-up algorithm:

1. Extended Medical Therapy

   • Increase INCS dose or add budesonide nasal irrigations
   • Consider extended macrolide therapy (e.g., azithromycin 250 mg three times weekly for 12 weeks)
   • Short repeat courses of oral steroids as needed

2. Biologic Therapy Evaluation
   Criteria commonly used:

   • Bilateral polyps with grade ≥ 2 despite maximal medical therapy
   • Need for ≥ 2 systemic steroid courses in past year
   • Comorbid asthma requiring high-dose inhaled steroids or systemic steroids
   • Evidence of type 2 inflammation (eosinophils ≥ 250 cells/µL, elevated IgE)

   Available agents:

   • Dupilumab (anti-IL-4Rα)
   • Mepolizumab (anti-IL-5)
   • Omalizumab (anti-IgE)

   Follow manufacturer's protocol for dosing and monitoring. Assess response at 16–24 weeks.

3. Endoscopic Sinus Surgery (ESS) Consideration
   Indications:

   • Persistent obstructive polyps despite optimized medical/biologic therapy
   • Complications (mucocele, orbital/intracranial extension)
   • Patient preference for surgical relief

   ESS goals:

   • Remove polyps and diseased mucosa
   • Restore sinus ventilation and drainage
   • Enhance delivery of topical therapies

---

4. Post-Treatment Maintenance & Follow-Up

After medical or surgical intervention, long-term care is crucial to reduce recurrence:

• Intranasal Corticosteroids
– Continue daily for life
– Use breath-holding technique to improve spray distribution

• Saline Irrigation
– At least twice daily, more if crusting or dryness
– Consider budesonide solution (off-label in many regions)

• Regular Endoscopic Surveillance
– 1 month post-surgery or post-biologic initiation
– Then every 3–6 months depending on recurrence risk

• Repeat Imaging
– CT scan at 1 year if symptoms recur or complications arise

• Comorbidity Management
– Optimize asthma control with a pulmonologist
– Address allergy triggers and consider immunotherapy

---

5. Special Considerations

1. Aspirin-Exacerbated Respiratory Disease (AERD)

   • Aspirin desensitization protocols under specialist care
   • High-dose leukotriene modifiers

2. Pediatric Patients

   • Lower steroid doses
   • Surgery only if medical therapy fails

3. Elderly or High-Risk Patients

   • Minimize systemic steroids
   • Rely more on topical therapies and biologics

---

6. When to Seek Urgent Care

While nasal polyps themselves are rarely life-threatening, complications can occur. Contact a doctor promptly if you experience:

• Sudden vision changes or eye pain
• Severe headache with fever or neck stiffness
• Swelling around the eyes or face
• Neurologic symptoms (weakness, confusion)

If you're experiencing symptoms but aren't sure whether they warrant immediate medical attention, start by using a Medically approved LLM Symptom Checker Chat Bot to help you understand your condition and determine your next steps.

---

Key Takeaways

• Official clinical care algorithms for managing bilateral polyposis emphasize a stepwise approach:

  1. Confirm diagnosis via endoscopy and imaging
  2. Start with intranasal steroids + saline irrigation
  3. Use short courses of oral steroids or antibiotics as needed
  4. Escalate to biologics if type 2 inflammation is evident
  5. Reserve surgery for refractory cases
  6. Maintain with long-term topical therapy and regular surveillance

• Collaboration between ENT specialists, allergists, and pulmonologists optimizes outcomes.

• Always discuss serious or life-threatening symptoms directly with a physician.

Remember: this overview is for educational purposes. Always speak to your doctor or an ENT specialist before making decisions about treatment.